Description
COR-L23/5010 has been derived from the parent line, COR-L23 by continuous exposure to increasing concentrations of doxorubicin (also known as adriamycin). The cells overexpress multidrug resistance-associated protein (MRP) and express a 190kDa membrane-protein connected to the degree of drug-resistance. COR-L23/5010 have a higher resistance than COR-L23/R.
Adherent Suspension
Aggregates in suspension
Suggested Medium
RPMI 1640 + 2mM Glutamine + 1.0µg/ml doxorubicin + 10% FBS
Quality Control
COR-L23/5010 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Shippment
COR-L23/5010 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
COR-L23/5010 Cell Line is for research use only
